A little help keeping your community in the loop. Good stories, good company.

Explore News.ggDiscord news bot World news for Discord Gaming news and patch notes RSS feeds for Discord Stock market alerts

Blog & GuidesNews.gg Blog Crypto News & Alerts Stock Market News Bots Gaming News Bots Setup Crypto Alerts Stocks Video Guide

ProductFeatures Dashboard Pricing Support

ResourcesBlog Help & Support Discord Server Twitter / X Changelog Developer API

CompanyCommunities Careers Log In Contact

LegalPrivacy Policy Terms of Service Cookie Policy

Spero Therapeutics CEO Rajavelu sells $42,485 in tax-related stock | News.gg

Thursday, November 12, 2026Coverage from every side, on News.ggInternational Edition

News.gg

Home Latest Off the Radar

Subscribe Login

Published Yesterday · Investing.com · Updated 7 hours ago

Spero Therapeutics CEO Rajavelu sells $42,485 in tax-related stock

Side-by-Side Framing

No summary available for this article yet.

Summary from the original article

Investing.comFactualityFactuality is a Premium featureHow reliably the outlets covering this story report facts, based on their track record of accuracy and corrections.Center

Palestinian Territories

CenterBased on the outlet's overall lean; article framing check pending

No description available for this article.

By Investing.com · Nov 11, 2026, 12:01 AM UTC

Read full article at Investing.com

Side-by-Side Framing

Premium

AI key points, how left, center and right framed this story, tone by side and loaded language are part of News.gg Premium.

Upgrade this server

2 Articles

Investing.comFactualityCenter
aim immunotech ceo equels buys $5,070 in company stock
8 hours ago · investing.com
Investing.comFactualityCenter
Spero Therapeutics CEO Rajavelu sells $42,485 in tax-related stock
Yesterday · investing.com · You are reading this one

Coverage Details

Total News Sources: 1
Leaning Left: 0
Leaning Right: 0
Center: 2
Last Updated: 7 hours ago
Bias Distribution: 100% Center

Bias Distribution

• 100% of the sources are Center

C 100%

Investing.comCenter · investing.com

Factuality

To view factuality data please Upgrade to Premium

Timeline

Nov 11, 2026, 12:01 AM UTC · first report
Investing.com Spero Therapeutics CEO Rajavelu sells $42,485 in tax-related stock
Nov 11, 2026, 6:31 PM UTC
Investing.com aim immunotech ceo equels buys $5,070 in company stock

Bias ratings are News.gg assessments of each article's wording compared with other outlets covering the same story.

Investing.com · 2 days ago

Wedbush lowers Perspective Therapeutics stock price target to $7

100% Center coverage: 1 source

Investing.com · Yesterday

Enovis director Sharon Wienbar buys $49,917 of company stock

100% Center coverage: 1 source

Investing.com · Yesterday

Exagen director Jorey Chernett sells $69,167 in shares, buys more

100% Center coverage: 1 source